Zacks: Dynatronics Co. (DYNT) Given $7.50 Average Price Target by Brokerages
Shares of Dynatronics Co. (NASDAQ:DYNT) have been given an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy rating.
Analysts have set a 1-year consensus target price of $7.50 for the company, according to Zacks. Zacks has also given Dynatronics an industry rank of 161 out of 265 based on the ratings given to related companies.
Separately, Zacks Investment Research lowered Dynatronics from a “hold” rating to a “sell” rating in a research note on Monday, September 4th.
A hedge fund recently bought a new stake in Dynatronics stock. First Light Asset Management LLC purchased a new stake in shares of Dynatronics Co. (NASDAQ:DYNT) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 100,000 shares of the medical equipment provider’s stock, valued at approximately $280,000. First Light Asset Management LLC owned 2.72% of Dynatronics as of its most recent SEC filing. 18.17% of the stock is currently owned by hedge funds and other institutional investors.
Dynatronics (DYNT) traded up $0.09 during midday trading on Thursday, reaching $2.64. The company’s stock had a trading volume of 223 shares, compared to its average volume of 13,798. Dynatronics has a one year low of $2.10 and a one year high of $3.75. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.92 and a current ratio of 1.46.
Dynatronics (NASDAQ:DYNT) last posted its earnings results on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.08. Dynatronics had a negative return on equity of 45.78% and a negative net margin of 3.42%. The company had revenue of $12.80 million for the quarter. analysts anticipate that Dynatronics will post -0.09 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was first posted by American Banking News and is the property of of American Banking News. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.americanbankingnews.com/2017/12/07/zacks-dynatronics-co-dynt-given-7-50-average-price-target-by-brokerages.html.
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Dynatronics Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics Co. and related companies with MarketBeat.com's FREE daily email newsletter.